Author: Bill Beeson

Weighing the Opportunities & Risks Within China’s Biopharmaceutical Industry

China’s biopharmaceuticals is an often overlooked yet quickly growing industry. In recent years, various regulatory reforms have transformed the industry, nurturing it into a global competitor. Many foreign investors are interested in taking advantage of the local industry’s streamlined product registration process and robust development incentives. However, there are still risks that investors should remain cognizant of when planning their entrance strategy into the Chinese biopharmaceutical market.

Scroll to Top